BCRX — BIOCRYST PHARMACEUTICALS INC

Ownership history in Focus Partners Wealth  ·  1 quarter on record

This page tracks every 13F SEC filing in which Focus Partners Wealth reported a position in BIOCRYST PHARMACEUTICALS INC (BCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 10,117 — — 0.00% $2.1M $7.59
% of Fund (quarterly)    BCRX price (monthly, adj. close)

Other funds also holding BCRX

As of 2025 Q4 — sorted by position size

Elmind Capital, LP 4.95% Kynam Capital Management, LP 3Y 4.67% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.43% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.26% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.26% Eversept Partners, LP 3Y 7Y 1.18% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 0.82% DAFNA Capital Management LLC 3Y 7Y 0.76% Parkman Healthcare Partners LLC 3Y 0.67% Vestal Point Capital, LP 0.6%
← Back to Focus Partners Wealth Holdings